An Open Label Phase 1b/2 Study of Orally Administered PLX3397 in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007344/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study objectives are to assess the potential for PLX3397 to improve the efficacy of
standard of care radiation therapy (RT) + temozolomide in patients with newly diagnosed
glioblastoma (GBM).
提供机构：
Vivli
创建时间：
2021-08-24
